16/07/2026
👏 Leading domestic enterprises join forces to pursue new growth. Applitech has sealed a project cooperation deal with CSPC, a top innovative pharmaceutical enterprise. Under this partnership, 24 units of AbioBundle 3L glass bioreactors and 4 units of AbioBundle 15L glass bioreactors have been delivered in batches.
🧩 These bioreactors support single or dual control modes, featuring flexible configuration and intuitive operation, and are well-suited for high-density cultivation of CHO cells with excellent tank parallelism. These bioreactors will serve eight major innovative R&D platforms of CSPC Pharmaceutical Group, advancing research and development programs covering monoclonal antibodies, bispecific antibodies, ADCs, mRNA vaccines, small-molecule drugs, nanomedicines and more.